DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1999 • 2,625 citations

Thalidomide is an inhibitor of angiogenesis.

1994 • 2,460 citations

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

2013 • 2,176 citations

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

2000 • 868 citations

Number Cruncher Statistical Systems (NCSS)

1985 • 829 citations

Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

1984 • 667 citations

Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

2002 • 562 citations

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

1998 • 553 citations

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

2001 • 553 citations

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

1999 • 499 citations

Treatment of multiple myeloma

2003 • 474 citations

The Treatment of Multiple Myeloma

1994 • 409 citations

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

1986 • 336 citations

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

2002 • 260 citations

Multiple myeloma treated with high dose intravenous melphalan

1987 • 251 citations

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.

1994 • 223 citations

Phase II Evaluation of Thalidomide in Patients With Metastatic Breast Cancer

2000 • 117 citations

Thalidomide neuropathy in patients treated for metastatic prostate cancer

2001 • 86 citations

High-Dose Melphalan With Autotransplantation for Refractory Multiple Myeloma: Results of a Southwest Oncology Group Phase II Trial

1999 • 81 citations

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

1997 • 61 citations

Thalidomide in the management of multiple myeloma

2001 • 54 citations

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

2000 • 43 citations

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

1999 • 28 citations

VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide–prednisone therapy (protocol MY 85)

1998 • 21 citations

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients

2002 • 13 citations